Effect of Lactobacillus plantarum IS-10506 supplementation with oral metronidazole for the treatment of bacterial vaginosis : a randomized placebo-controlled clinical trial
DOI:
https://doi.org/10.66344/jpad.v32i4.2005Abstract
Background Replacement of Lactobacillus spp. by anaerobic and facultative bacteria is central in pathogenesis of bacterial vaginosis (BV). Oral metronidazole is currently recommended treatment. However, cure rate is variable. Probiotic supplementation was explored as alternative therapy. This study aimed to find out the effect of oral microencapsulated Lactobacillus plantarum IS-10506 supplementation on oral metronidazole 500 mg twice daily for the treatment of BV.
Methods Twenty nine females with BV were treated with oral metronidazole and randomized into probiotic (Pro) (n=14) and placebo (Pla) (n=15) groups. Pro group received microencapsulated L. plantarum IS-10506 supplementation at 0.9x109 CFU, twice daily. Pla group received placebo twice daily. Cure is defined from Amsel criteria and Nugent score 0-3. Metronidazole was stopped if subjects were cured. Probiotic and placebo were continued for 4 weeks. Cure rate and mean Nugent score were assessed at baseline, end of week 1, 2 and 4.
Results Mean Nugent score for Pro against Pla group were 8.07 vs. 8.07, 5.36 vs. 6.20, 4.07 vs. 4.93, and 3.57 vs. 4.33 respectively at baseline, end of week 1, 2 and 4. Cure rate for Pro against Pla group were 28.6% vs 20.0%, 50.0% vs 33.3%, 64.3% vs 40.0% respectively at end of week 1, 2 and 4. Mean Nugent score significantly decreased in both groups at end of week 1, 2 and 4 (p£0.05). Although not statistically significant, mean Nugent score was lower and cure rate was higher in Pro than Pla group at end of week 1, 2 and 4 (p>0.05). No adverse effect was recorded.
Conclusion Oral probiotic L. plantarum IS-10506 supplementation in addition to oral metronidazole was safe and potentially better than oral metronidazole alone for the treatment of BV. Studies with longer probiotic supplementation and more subjects may be required to demonstrate significant effect of this combination treatment on BV.
References
1. Manuputty AG, Matodiharjo S. The Profile of Bacterial Vaginosis in Academic Hospital Surabaya: A Retrospective Study. Berk Ilmu Kesehat Kulit dan Kelamin-Period Dermatology Venereol. 2020;32(2):141.
2. Saraf VS, Sheikh SA, Ahmad A, et al. Vaginal microbiome: normalcy vs. dysbiosis. Arch Microbiol. 2021;203(7):3793–802.
3. Joseph RJ, Ser HL, Kuai YH, et al. Finding a balance in the vaginal microbiome: How do we treat and prevent the occurrence of bacterial vaginosis? Antibiotics. 2021;10(6):1–39.
4. Hidayati AN, Liuwan CC. Peran Biofilm terhadap Infeksi Saluran Genital yang disebabkan oleh Vaginosis Bakterial (The Role of Biofilm in Genital Tract Infection Caused by Bacterial Vaginosis). Berk Ilmu Kesehat Kulit dan Kelamin-Period Dermatology Venereol. 2019;31(2):150–8.
5. Abou Chacra L, Fenollar F, Diop K. Bacterial Vaginosis: What Do We Currently Know? Front Cell Infect Microbiol. 2022;11:1–13.
6. Anukam K, Osazuwa E, Ahonkhai I, et al. Augmentation of antimicrobial metronidazole therapy of bacterial vaginosis with oral probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14: randomized, double-blind, placebo controlled trial. Microbes Infect. 2006;8(6):1450–4.
7. Wu S, Hugerth LW, Schuppe-Koistinen I, et al. The right bug in the right place: opportunities for bacterial vaginosis treatment. Npj Biofilms Microbiomes. 2022;8(1):34.
8. Cianci A, Cicinelli E, De Leo V, et al. Observational prospective study on Lactobacillus plantarum P 17630 in the prevention of vaginal infections, during and after systemic antibiotic therapy or in women with recurrent vaginal or genitourinary infections. J Obstet Gynaecol (Lahore). 2018;38(5):693–6.
9. Lin TC, Hsu IL, Tsai WH, et al. Improvement of bacterial vaginosis by oral lactobacillus supplement: A randomized, double-blinded trial. Appl Sci. 2021;11(3):1–21.
10. Prakoeswa CRS, Bonita L, Karim A, et al. Beneficial effect of Lactobacillus plantarum IS-10506 supplementation in adults with atopic dermatitis: a randomized controlled trial. J Dermatolog Treat. 2022;33:1491-8.
11. Prakoeswa CRS, Herwanto N, Prameswari R, et al. Lactobacillus plantarum IS-10506 supplementation reduced SCORAD in children with atopic dermatitis. Benef Microbes. 2017;8(5):833–40.
12. Surono IS. Ethnic fermented foods and alcoholic beverages of Indonesia. In: Tamang JP, editor. Ethnic Fermented Foods and Alcoholic Beverages of Asia. Delhi: Springer India; 2016. p. 341–82.
13. Adib A, H. Wahid M, Sudarmono P, et al. Lactobacillus plantarum PADA FESES INDIVIDU DEWASA SEHAT YANG MENGONSUMSI Lactobacillus plantarum IS-10506 DARI DADIH. J Teknol dan Ind Pangan. 2013;24(2):154–61.
14. Surono I, Verhoeven J, Verbruggen S, et al. Microencapsulation increases survival of the probiotic Lactobacillus plantarum IS-10506, but not Enterococcus faecium IS-27526 in a dynamic, computer-controlled in vitro model of the upper gastrointestinal tract. J Appl Microbiol. 2018;124(6):1604–9.
15. Collado MC, Surono IS, Meriluoto J, et al. Potential probiotic characters of Lactobacillus and Enterococcus strains isolated from traditional dadih fermented milk against pathogen intestinal colonization. J Food Prot. 2007;70(3):700–5.
16. Collado MC, Surono I, Meriluoto J, et al. Indigenous dadih lactic acid bacteria: Cell-surface properties and interactions with pathogens. J Food Sci. 2007;72(3):89–93.
17. Lim MLR, Lasala L. Effectiveness and safety of metronidazole plus probiotics versus metronidazole alone in the treatment of bacterial vaginosis: randomized controlled trial. SPMC J Heal Care Serv. 2015;1(1):31-7.
18. Muñoz-Barreno A, Cabezas-Mera F, Tejera E, et al. Comparative effectiveness of treatments for bacterial vaginosis: A network meta-analysis. Antibiotics. 2021;10(8):1–16.
19. Li C, Wang T, Li Y, et al. Probiotics for the treatment of women with bacterial vaginosis: A systematic review and meta-analysis of randomized clinical trials. Eur J Pharmacol. 2019;864:172660.
20. Wirantari N, Hidayati AN. Peran Lactobacillus Pada Managemen Infeksi Endogen Genitalia Wanita. Media Dermato-Venereologica Indones. 2019;45(2):100–4.
21. Heczko PB, Tomusiak A, Adamski P, et al. Supplementation of standard antibiotic therapy with oral probiotics for bacterial vaginosis and aerobic vaginitis: A randomised, double-blind, placebo-controlled trial. BMC Womens Health. 2015;15(1):1–12.
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Afif Nurul Hidayati, Ridha Ramadina Widiatma, Dwi Murtiastutik, Ingrid Suryanti Surono, Cita Rosita Sigit Prakoeswa, Lunardi Bintanjoyo
This work is licensed under a Creative Commons Attribution 4.0 International License.
Submission declaration
Authors retain the copyright to their work and grant the 'Journal of Pakistan Association of Dermatologists (JPAD)' the right of first publication under a Creative Commons Attribution 4.0 International (CC BY 4.0) license. This license allows others to share, adapt, and reuse the work for any purpose, including commercial use, as long as appropriate credit is given to the original authors and the journal.
By submitting a manuscript, authors confirm that the work has not been published previously (except as an abstract, lecture, or academic thesis), is not under review elsewhere, and has been approved by all authors and relevant authorities. Once accepted, the article will be openly accessible under the CC BY 4.0 license, ensuring wide dissemination and reuse with proper attribution.
